ARID1A and neoplasm: The role of ARID1A as a tumor suppressor in CRC was previously validated using genetically engineered mouse models, where ARID1A null mice exhibited increased spontaneous tumor formation in the large intestine and decreased overall survival following systemic treatment with the inflammatory stimulant Poly(I:C) [22].